NXI Therapeutics
PrivateLast Round
Pre Seed
Jun 18, 2024
Total Funding Raised
$3.95M
Company Overview
NXI Therapeutics is a biotechnology company that develops a novel class of selective immunosuppressant drugs designed to treat autoimmune diseases and prevent organ transplant rejection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NXI Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NXI Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jun 18, 2024 |
Key People
Founding team and executive leadership
NXI Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Pre Seed |
| JFG Life Sciences Foundation of the University of Basel | Pre Seed |
| BaseLaunch | Pre Seed |
| Venture Kick | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors increased 87% MoM.
- Dec 21, 2024
Monthly visitors grew 2985% MoM, from 13 to 401.
NXI Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NXI Therapeutics's valuation, stock price, and market status.